1 |
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
DOI
|
2 |
DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64:252-271.
DOI
|
3 |
Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-141.
DOI
|
4 |
Cuschieri SA, Hanna GB. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma: let us move on to another era. Ann Surg 2014;259:e90.
DOI
|
5 |
Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg 2011;253:900-911.
DOI
|
6 |
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998;1:10-24.
DOI
|
7 |
Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010;17:3077-3079.
DOI
|
8 |
Kim SS, Choi BY, Seo SI, Jung MY, Choi HS, Ahn SM, et al. The comparison between 6th and 7th International Union against Cancer/American Joint Committee on Cancer classification for survival prognosis of gastric cancer. Korean J Gastroenterol 2011;58:258-263.
DOI
|
9 |
Kim JH, Kim CW, Choi NK, Kwak JH, Choi KM, Jang HJ, et al. The comparison between 6th and 7th UICC/AJCC N Stage for prognostic significance in gastric cancer. J Korean Surg Soc 2010;79:202-206.
DOI
|
10 |
Imamura T, Komatsu S, Ichikawa D, Kubota T, Okamoto K, Konishi H, et al. Poor prognostic subgroup in T3N0 stage IIA gastric cancer, suggesting an indication for adjuvant chemotherapy. J Surg Oncol 2015;111:221-225.
DOI
|
11 |
Rausei S, Dionigi G, Ruspi L, Proserpio I, Galli F, Tirotta F, et al. Lymph node staging in gastric cancer: new criteria, old problems. Int J Surg 2013;11 Suppl 1:S90-S94.
DOI
|
12 |
Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi K. Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol 1997;4:137-140.
DOI
|
13 |
Kim DY, Seo KW, Joo JK, Park YK, Ryu SY, Kim HR, et al. Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol 2006;12:1182-1186.
DOI
|
14 |
Yokota T, Ishiyama S, Saito T, Teshima S, Yamada Y, Iwamoto K, et al. Is tumor size a prognostic indicator for gastric carcinoma? Anticancer Res 2002;22:3673-3677.
|
15 |
Zhang BY, Yuan J, Cui ZS, Li ZW, Li XH, Lu YY. Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer. Am J Surg 2014;207:555-565.
DOI
|
16 |
He H, Shen Z, Wang X, Qin J, Sun Y, Qin X. Survival benefit of greater number of lymph nodes dissection for advanced nodenegative gastric cancer patients following radical gastrectomy. Jpn J Clin Oncol 2016;46:63-70.
DOI
|
17 |
Dicken BJ, Graham K, Hamilton SM, Andrews S, Lai R, Listgarten J, et al. Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg 2006;243:64-73.
DOI
|
18 |
Lee JH, Kim MG, Jung MS, Kwon SJ. Prognostic significance of lymphovascular invasion in node-negative gastric cancer. World J Surg 2015;39:732-739.
DOI
|